Emergency living related liver transplantation for fulminant reactivation of hepatitis B virus after unrelated marrow transplantation

Clinical Transplantation

Volumn 17, Issue 2, 2003, Pages 121-125

  Au, W Y ^a   Lau, G K K ^a   Lie, A K W ^a   Liang, R ^a   Lo, C M ^a   Fan, S T ^a   Liu, C L ^a   Hawkins, B R ^a   Ng, I O L ^a   Kwong, Y L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Hepatitis B virus; Living related donor; Marrow transplantation; Orthotopic liver transplantation

Indexed keywords

ALPHA FETOPROTEIN; AZATHIOPRINE; BCR ABL PROTEIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FAMCICLOVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HLA ANTIGEN; LAMIVUDINE; METHOTREXATE; METHYLPREDNISOLONE; OKT 3; PREDNISOLONE; TACROLIMUS; VIRUS DNA;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG WITHDRAWAL; EMERGENCY SURGERY; FEMALE; GRAFT REJECTION; GRAFT VERSUS LEUKEMIA EFFECT; HEPATITIS B; HEPATITIS B VIRUS; HLA MATCHING; HUMAN; IMMUNE DEFICIENCY; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; RECIPIENT; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; VIRUS IMMUNITY; VIRUS REACTIVATION;

ADULT; BONE MARROW TRANSPLANTATION; EMERGENCIES; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS;

EID: 0038301998     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.00022.x     Document Type: Article

References (18)

1. Bunin N, Leahey A, Dunn S. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation. Transplantation 1996: 61: 664.
2. Rosen HR, Martin P, Schiller GJ et al. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transpl Surg 1996: 2: 225.
3. Matthes-Martin S, Peters C, Konigsrainer A et al. Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood 2000: 96: 3997.
4. Liang R, Lau GK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol 1999: 17: 394.
5. Lau GK, Suri D, Liang R et al. Resolution of chronic hepatitis B and Anti-HBs seroconversion in man by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002: 122: 614.
6. Au WY, Lo CM, Hawkins BR, Ma ES, Lie AK, Kwong YL. Evans' syndrome complicating chronic graft versus host disease after cadaveric liver transplantation. Transplantation 2001: 72: 527.
7. Lo CM, Cheung ST, Lai CL et al. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg 2001: 233: 276.
8. Liu JP, McIntosh H, Lin H. Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection. Cochrane Database Syst Rev 2001: 2: 2231.
9. Dey B, Sykes M, Spitzer TR. Outcomes of recipients of both bone marrow and solid organ transplants. Medicine 1998: 77: 355.
10. Nimer SD, Milewicz AL, Champlin RE, Busuttil RW. Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation. Transplantation 1990: 49: 819.
11. Figuera A, Tomas JF, Otero MJ, Moreno E, Garcia I, Fernandez-Ranada JM. Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation. Am J Hematol 1996: 52: 68.
12. Rapoport AP, Doyle HR, Starzl T, Rowe JM, Doeblin T, Dipersio JF. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant. Bone Marrow Transplant 1991: 8: 421.
13. Dowlati A, Honore P, Damas P et al. Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation. Transplantation 1995: 60: 106.
14. Schlitt HJ, Tischler HJ, Ringe B et al. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation - clinical and immunological considerations. Bone Marrow Transplant 1995: 16: 473.
15. Marks DI, Dousset B, Robson A et al. Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia. Bone Marrow Transplant 1992: 10: 463.
16. Jonsson JR, Hogan PG, Thomas R et al. Peripheral blood chimerism following human liver transplantation. Hepatology 1997: 25: 1233.
17. Rhodes DF, Lee WM, Wingard JR et al. Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation. Gastroenterology 1990: 99: 536.
18. Ricordi C, Karatzas T, Nery J et al. High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 1997: 63: 7.